CURE Pharmaceutical to Present at CannX 2018 International Medical Cannabis Conference
10 oct. 2018 07h25 HE
|
CURE Pharmaceutical
OXNARD, Calif., Oct. 10, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, will be presenting at this year's CannX Conference on October...
CURE Pharmaceutical to Present at The MicroCap Conference on October 1st and 2nd in New York City at the Essex House
28 sept. 2018 07h25 HE
|
CURE Pharmaceutical
NEW YORK, Sept. 28, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, will be presenting at this year's MicroCap Conference on October...
CURE Pharmaceutical Secures Patent for Oral Thin Film Containing Bioactive Cannabinoid Molecules
25 sept. 2018 08h45 HE
|
CURE Pharmaceutical
LOS ANGELES, Sept. 25, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, announced the allowance of an oral thin film patent (U.S. Patent...
CURE Pharmaceutical Expands Distribution of CUREfilm Technology with First Licensing Agreement
05 sept. 2018 08h57 HE
|
CURE Pharmaceutical
LOS ANGELES, Sept. 05, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), (“CURE”), an innovative drug delivery and development company, today announced that it entered into a multi-year...
Cure Pharmaceutical Plans to Acquire Cannabinoid-Based Drug Pipeline from Therapix Biosciences Ltd.
11 juil. 2018 08h57 HE
|
CURE Pharmaceutical
OXNARD, Calif., July 11, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), an innovative drug delivery and development company, announced today that it has signed a term sheet...
CURE Pharmaceutical to Present on the Increased Bioavailability for Cannabinoids Due to New Delivery Technologies at O’Cannabiz Conference
05 juin 2018 08h57 HE
|
CURE Pharmaceutical
LOS ANGELES, June 05, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced that CEO Rob Davidson will be presenting at the...
CURE Pharmaceutical to Showcase Company Growth at the 8th LD Micro Invitational
23 mai 2018 08h57 HE
|
CURE Pharmaceutical
LOS ANGELES, May 23, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced that it will be presenting at the 8th annual LD...
CURE Pharmaceutical Attracts Strategic Investment to Speed Its Cannabinoid Drug Delivery Production
01 mai 2018 08h57 HE
|
CURE Pharmaceutical
OXNARD, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced it received an investment of $500,000 from a...
CURE Pharmaceutical Secures Two Patents for the Extraction and Purification of Bioactive Cannabinoid Molecules
04 avr. 2018 08h57 HE
|
CURE Pharmaceutical
LOS ANGELES, April 04, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the acquisition of two patents that ensure CURE...
CURE Pharmaceutical Reports Strong Progress and Sets Growth Roadmap for Remainder of Year
03 avr. 2018 08h57 HE
|
CURE Pharmaceutical
OXNARD, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery company, today reported the company’s Q1 2018 accomplishments. The company strengthened...